We’ve received numerous inquiries from panicked readers regarding a recent Instagram post from WPIX-TV 11 (New York) that has sparked concern:

Despite the post featuring an image of old-style EpiPen auto-injectors, this recall does NOT involve auto-injectors of any kind.
The Facts:
- The Product: The recall strictly involves vials of epinephrine manufactured by Fresenius Kabi.
- The Quantity: 898,050 vials are affected.
- The Date: The recall was initiated on May 14, 2026.
- The Target Audience: These vials are generally utilized by healthcare professionals in hospitals, clinics, and private practices.
What This Means For You:
For Patients: Unless you have been specifically prescribed epinephrine in vial form (which requires a separate syringe to administer), you are not affected by this recall. Your standard EpiPens or other auto-injectors are perfectly safe to use.
For Physicians & Medical Staff: If you rely on epinephrine vials to treat patients in your practice, please review the official Fresenius Kabi recall announcement to check the lot numbers in your inventory.
Note: We have reached out via the appropriate channels to request the removal or correction of the misleading social media post.
- Instagram Post — WPIX 11 News
- Enforcement Report — US Food & Drug Administration
- Urgent Drug Recall — Fresenius Kabi
